BackImmunoPrecise Antibodies Overview

ImmunoPrecise Antibodies Research & Development

Research & Development expenses for IPA.

Quarterly R&D Expenses

$1.19M
↑ 12.98% YoY

As of Jan 31, 2026

Annual R&D Expenses (TTM)

$4.57M
↓ 4.42% YoY

Trailing 12 months ending Jan 31, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin